Corporate Gossip cover image

McKinsey: This is why we can't have nice things

Corporate Gossip

00:00

McKinsey's Involvement in Boosting OxyContin Sales and Its Consequences

This chapter discusses McKinsey's strategies to boost sales of Purdue Pharma's OxyContin painkiller during the opioid epidemic, including rebates for overdose deaths and targeting younger patients. It also highlights the tragic impact of opioids on individuals and the disclosure of McKinsey's involvement.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app